Original
Sustitución de procarbazina por etopósido en un nuevo esquema de tratamiento OEPA/COPE en los niños y adolescentes con linfoma de Hodgkin: una evaluación de los resultados en el Instituto Nacional de Cancerología
Replacing procarbazine with etoposide in a new OEPA/COPE treatment scheme in children and adolescents with Hodgkin lymphoma: An evaluation of outcomes in the National Cancer Institute
Leído
7721
Vecesse ha leído el artículo
1234
Total PDF
6487
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 30 | 4 | 34 |
| 2025 11 | 74 | 17 | 91 |
| 2025 10 | 56 | 15 | 71 |
| 2025 9 | 70 | 14 | 84 |
| 2025 8 | 70 | 13 | 83 |
| 2025 7 | 83 | 15 | 98 |
| 2025 6 | 68 | 10 | 78 |
| 2025 5 | 82 | 8 | 90 |
| 2025 4 | 95 | 9 | 104 |
| 2025 3 | 113 | 16 | 129 |
| 2025 2 | 78 | 10 | 88 |
| 2025 1 | 98 | 10 | 108 |
| 2024 12 | 76 | 8 | 84 |
| 2024 11 | 85 | 7 | 92 |
| 2024 10 | 65 | 3 | 68 |
| 2024 9 | 87 | 2 | 89 |
| 2024 8 | 67 | 4 | 71 |
| 2024 7 | 86 | 10 | 96 |
| 2024 6 | 77 | 6 | 83 |
| 2024 5 | 51 | 5 | 56 |
| 2024 4 | 41 | 2 | 43 |
| 2024 3 | 46 | 10 | 56 |
| 2024 2 | 86 | 20 | 106 |
| 2024 1 | 86 | 15 | 101 |
| 2023 12 | 88 | 16 | 104 |
| 2023 11 | 103 | 8 | 111 |
| 2023 10 | 87 | 10 | 97 |
| 2023 9 | 45 | 13 | 58 |
| 2023 8 | 72 | 16 | 88 |
| 2023 7 | 78 | 26 | 104 |
| 2023 6 | 75 | 13 | 88 |
| 2023 5 | 75 | 11 | 86 |
| 2023 4 | 70 | 3 | 73 |
| 2023 3 | 52 | 8 | 60 |
| 2023 2 | 46 | 3 | 49 |
| 2022 1 | 49 | 3 | 52 |
| 2022 12 | 52 | 13 | 65 |
| 2022 11 | 66 | 7 | 73 |
| 2022 10 | 35 | 9 | 44 |
| 2022 9 | 46 | 11 | 57 |
| 2022 8 | 43 | 13 | 56 |
| 2022 7 | 30 | 11 | 41 |
| 2022 6 | 33 | 9 | 42 |
| 2022 5 | 38 | 12 | 50 |
| 2022 4 | 78 | 9 | 87 |
| 2022 3 | 119 | 12 | 131 |
| 2022 2 | 119 | 15 | 134 |
| 2021 1 | 101 | 10 | 111 |
| 2021 12 | 57 | 16 | 73 |
| 2021 11 | 62 | 7 | 69 |
| 2021 10 | 84 | 16 | 100 |
| 2021 9 | 40 | 9 | 49 |
| 2021 8 | 54 | 6 | 60 |
| 2021 7 | 38 | 12 | 50 |
| 2021 6 | 45 | 9 | 54 |
| 2021 5 | 32 | 5 | 37 |
| 2021 4 | 101 | 23 | 124 |
| 2021 3 | 72 | 16 | 88 |
| 2021 2 | 30 | 9 | 39 |
| 2020 1 | 39 | 10 | 49 |
| 2020 12 | 49 | 9 | 58 |
| 2020 11 | 58 | 9 | 67 |
| 2020 10 | 27 | 9 | 36 |
| 2020 9 | 36 | 11 | 47 |
| 2020 8 | 42 | 11 | 53 |
| 2020 7 | 35 | 10 | 45 |
| 2020 6 | 22 | 8 | 30 |
| 2020 5 | 30 | 10 | 40 |
| 2020 4 | 38 | 7 | 45 |
| 2020 3 | 34 | 11 | 45 |
| 2020 2 | 27 | 4 | 31 |
| 2020 1 | 28 | 5 | 33 |
| 2019 12 | 37 | 7 | 44 |
| 2019 11 | 34 | 11 | 45 |
| 2019 10 | 39 | 8 | 47 |
| 2019 9 | 43 | 6 | 49 |
| 2019 8 | 32 | 4 | 36 |
| 2019 7 | 52 | 21 | 73 |
| 2019 6 | 114 | 42 | 156 |
| 2019 5 | 255 | 67 | 322 |
| 2019 4 | 118 | 34 | 152 |
| 2019 3 | 34 | 4 | 38 |
| 2019 2 | 22 | 9 | 31 |
| 2019 1 | 25 | 8 | 33 |
| 2018 12 | 20 | 3 | 23 |
| 2018 11 | 26 | 5 | 31 |
| 2018 10 | 40 | 11 | 51 |
| 2018 9 | 15 | 7 | 22 |
| 2018 8 | 24 | 10 | 34 |
| 2018 7 | 25 | 1 | 26 |
| 2018 6 | 18 | 2 | 20 |
| 2018 5 | 23 | 3 | 26 |
| 2018 4 | 18 | 1 | 19 |
| 2018 3 | 23 | 0 | 23 |
| 2018 2 | 23 | 1 | 24 |
| 2018 1 | 12 | 0 | 12 |
| 2017 12 | 12 | 0 | 12 |
| 2017 11 | 31 | 2 | 33 |
| 2017 10 | 16 | 1 | 17 |
| 2017 9 | 25 | 2 | 27 |
| 2017 8 | 22 | 5 | 27 |
| 2017 7 | 19 | 3 | 22 |
| 2017 6 | 28 | 1 | 29 |
| 2017 5 | 43 | 5 | 48 |
| 2017 4 | 25 | 8 | 33 |
| 2017 3 | 27 | 17 | 44 |
| 2017 2 | 32 | 5 | 37 |
| 2016 1 | 31 | 2 | 33 |
| 2016 12 | 50 | 13 | 63 |
| 2016 11 | 51 | 5 | 56 |
| 2016 10 | 81 | 10 | 91 |
| 2016 9 | 76 | 14 | 90 |
| 2016 8 | 72 | 12 | 84 |
| 2016 7 | 52 | 7 | 59 |
| 2016 6 | 43 | 17 | 60 |
| 2016 5 | 35 | 25 | 60 |
| 2016 4 | 57 | 21 | 78 |
| 2016 3 | 51 | 15 | 66 |
| 2016 2 | 42 | 20 | 62 |
| 2015 1 | 42 | 21 | 63 |
| 2015 12 | 2 | 2 | 4 |
Mostrar todo
